Display Settings:

Format

Send to:

Choose Destination

    Lancet. 2004 May 15;363(9421):1608-10.

    Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites.

    Albillos A, de-la-Hera A, Alvarez-Mon M.

    Laboratorio de Enfermedades del Sistema Inmune y Oncología, Unidad I+D Asociada al CSIC, Departamento de Medicina, Universidad de Alcalá, Carretera Madrid-Barcelona, KM 33.600, 28871 Alcalá de Henares, Madrid, Spain. aalbillosm@meditex.es

    Serum lipopolysaccharide-binding protein is increased in a subset of non-infected ascitic cirrhotic patients, a finding previously related to bacterial passage from the gut to the circulation without overt infection. We prospectively analysed the risk factors associated with a first episode of severe bacterial infection in 84 ascitic cirrhotics, followed up for a median of 46 weeks. The cumulative probability of such infection in patients with raised and normal lipopolysaccharide-binding protein was 32.4% and 8.0% (p=0.004), respectively. Increased lipopolysaccharide-binding protein was the only factor independently associated with severe bacterial infection in a multivariate analysis (relative risk 4.49, 95% CI 1.42-14.1). Monitoring of serum lipopolysaccharide-binding protein could, therefore, help to target cirrhotic patients with ascites for antibiotic prophylaxis.

    PMID: 15145636 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read Click here to read Click here to read Click here to read